3D Structure Prediction of TAS2R38 Bitter Receptors Bound to Agonists Phenylthiocarbannide (PTC) and 6-n-Propyithiouracil (PROP)

The G protein-coupled receptor (GPCR) TAS2R38 is a bitter taste receptor that can respond to bitter compounds such as phenylthiocarbamide (PTC) and 6-n-propylthiouracil (PROP). This receptor was chosen because its four haplotypes (based on three residue site polymorphism) hTAS2R38(PAV), hTAS2R38(AVI), hTAS2R38(AAI), and hTAS2R38(PVV) are known to have dramatically different responses to PTC and PROP. We aimed to identify the protein ligand interaction features that determine whether the bitter taste signal from this receptor is sent to the cortex. To do this we predicted the 3D structures of the TAS2R38 bitter taste receptor using our new BiHelix and SuperBiHelix Monte Carlo methods (No experimental determinations of the 3D structure have been reported for any taste receptors.). We find that residue 262 (2nd position in the polymorphism) is involved in the interhelical hydrogen bond network stabilizing the GPCR structure in tasters (hTAS2R38(PAV), hTAS2R38(AAI), and hTAS2R38(PVV)), while it is not in the nontaster (hTAS2R38(AVI)). This suggests that the hydrogen bond interactions between TM3 and TM6 or between TM5 and TM6 may play a role in activating this GPCR To further validate these structures, we used the DarwinDock method to predict the binding sites and 3D structures for PTC and PROP bound to hTAS2R38(PAV), hTAS2R38(AVI), hTAS2R38(AAI), and hTAS2R38(PVV), respectively. Our results show that PTC and PROP can form H-bonds with the backbone of residue 262 in the tasters (hTAS2R38pAv, hTAS2R38(AAI), and hTAS2R38(PVV)) but not in the nontaster (hTAS2R38(AVI)). Thus it appears that the hydrogen bond interaction between TM3 and TM6 may activate the receptor to pass the ligand binding signal to intracellular processes and that the H-bond between agonists and residue 262 in tasters is involved in the bitter tasting. This is in agreement with experimental observations, providing validation of the predicted ligand-protein complexes and also a potential activation mechanism for the TAS2R38 receptor.